The
carbon–carbon (C–C) bond cleavage of cyclopropanols
is a wide area of research with much current activity. This review
highlights new developments in this area over the past two decades.
A summary is made of the three main reactivity modes, namely, homoenolate
chemistry, β-keto radical chemistry, and acid-catalyzed ring-opening,
as well as all other methods for the C–C bond cleavage and
functionalization of cyclopropanols, including base-mediated ring-opening,
metal-catalyzed C–C insertions and eliminations, oxidative
fragmentation using hypervalent iodine reagents, reactions of donor–acceptor
cyclopropanols, and pericylic reactions. Emphasis is placed on the
synthetic utility of cyclopropanols and related derivatives, which
have emerged as unique three-carbon synthons.
Cobalt(II)
halides in combination with phenoxyimine (FI) ligands
generated efficient precatalysts in situ for the
C(sp2)–C(sp3) Suzuki–Miyaura cross-coupling
between alkyl bromides and neopentylglycol (hetero)arylboronic esters.
The protocol enabled efficient C–C bond formation with a host
of nucleophiles and electrophiles (36 examples, 34–95%) with
precatalyst loadings of 5 mol %. Studies with alkyl halide electrophiles
that function as radical clocks support the intermediacy of alkyl
radicals during the course of the catalytic reaction. The improved
performance of the FI–cobalt catalyst was correlated with decreased
lifetimes of cage-escaped radicals as compared to those of diamine-type
ligands. Studies of the phenoxyimine–cobalt coordination chemistry
validate the L,X interaction leading to the discovery of an optimal,
well-defined, air-stable mono-FI–cobalt(II) precatalyst structure.
The
ability to understand and predict reactivity is essential for
the development of new reactions. In the context of Ni-catalyzed C(sp3)–O functionalization, we have developed a unique strategy
employing activated cyclopropanols to aid the design and optimization
of a redox-active leaving group for C(sp3)–O arylation.
In this chemistry, the cyclopropane ring acts as a reporter of leaving-group
reactivity, since the ring-opened product is obtained under polar
(2e) conditions, and the ring-closed product is obtained under radical
(1e) conditions. Mechanistic studies demonstrate that the optimal
leaving group is redox-active and are consistent with a Ni(I)/Ni(III)
catalytic cycle. The optimized reaction conditions are also used to
synthesize a number of arylcyclopropanes, which are valuable pharmaceutical
motifs.
Herein, we report a Ni-catalyzed reductive coupling for the synthesis of benzonitriles from aryl (pseudo)halides and an electrophilic cyanating reagent, 2methyl-2-phenyl malononitrile (MPMN). MPMN is a bench-stable, carbon-bound electrophilic CN reagent that does not release cyanide under the reaction conditions. A variety of medicinally relevant benzonitriles can be made in good yields. Addition of NaBr to the reaction mixture allows for the use of more challenging aryl electrophiles such as aryl chlorides, tosylates, and triflates. Mechanistic investigations suggest that NaBr plays a role in facilitating oxidative addition with these substrates.
Metal homoenolates, produced via C-C bond cleavage of cyclopropanols, have been extensively investigated as nucleophiles for the synthesis of β-substituted carbonyl derivatives. Herein, we demonstrate that zinc homoenolates can react as carbonyl-electrophiles in the presence of nucleophilic amines to yield highly valuable trans-cyclopropylamines in good yields and high diastereoselectivities. GSK2879552, a lysine demethylase 1 inhibitor currently in clinical trials for the treatment of small cell lung carcinoma, was synthesized using this strategy.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.